Cape Town, 8 July 2022 – U.S. government researchers have agreed to collaborate with Afrigen Biologics Limited to share technical expertise related to the development of next-generation mRNA vaccines and
Read FullAfrica has huge potential to manufacture vaccines that cater to the needs of its growing population, says a top Kenyan policy maker. “Africa is the fastest growing continent, and we
Read FullBuyers United: How Low- and Middle-Income Countries Can Get a Better Deal on Pharmaceuticals Cape Town’s Afrigen Vaccines & Biologics laboratory. The company has now made a deal with Univercells
Read FullWorld Immunization Week (WIW), celebrated in the last week of April, aims to highlight the importance of vaccines and how they protect people of all ages against many diseases, giving
Read FullWe celebrate the many women around the world contributing to #science and #innovationforeveryone 👩🏾🔬 📽️. https://lnkd.in/eHEtA2dM Ministère des Affaires étrangères français Swiss Agency for Development and Cooperation Biovac Afrigen Biologics (Pty) Ltd Africa Centres for Disease Control and
Read FullThermo Fisher Scientific in partnership with Afrigen Biologics (Pty) Ltd and Labotec to drive mRNA vaccine development and supply in South Africa and beyond. View here #innovation #partnerships #AfricainSTEM #southafrica #development #thermofisherscientific
Read FullIn January, Cape Town-based biotechnology company Afrigen Biologics announced that it has successfully produced a lab-scale batch of a COVID-19 vaccine that is similar to that made by pharmaceutical company
Read FullLess than 20% of Africans are fully vaccinated against COVID-19. But vaccine inequity exists within Africa as well as between the continent and the rest of the world, with some
Read Full